[5] Sathler P.C., Lourenҫo A. L., Rodrigues C. R., da silva L.C., Cabral L.M., Jordӑo A. K., Cunha A. C., Vieira M. C., Ferreira V. F., Carvalho-Pinto C. E., Kang H. C., Castro H.C.,
In Vitro and in Vivo Analysis of the Antithrombotic and Toxicological Profile of New Antiplatelets N-Acylhydrazone Derivatives and Development of Nanosystems Determination of Novel NAH Derivatives Antiplatelet and Nanotechnological Approach, Thromb Res,
134(2): 376-383 (2014).
[9] Pais C. G., Zhang X., Marchand C., Neamati N., Cowansage K., Svarovskaia E.S., Pathak V.K., Tang Y., Nicklaus M., Pommier Y., Burke T.R.,
Structure Activity of 3-Aryl-1,3-diketo-Containing Compounds as HIV-1 Integrase Inhibitors,
J. Med. Chem,
45: 3184-3194 (2002).
[11] Nazare M., Essrich M., Will D.W., Matter H., Ritter K., Urmann M., Bauer A., Schreuder H., Dudda A., Czech J., Lorenz M., Laux V., Wehner V,
Factor Xa Inhibitors Based on A2-Carboxyindole Scaffold: SAR of Neutral P1 Substituents,
Bioorg Med Chem Lett,
14(16): 4191-4195, (2004).
[13] Mirfazli S. S., Kobarfard F., Firoozpour L., Asadipour A., Esfahanizadeh M., Tabib K., Shafiee A., Foroumadi A.,
N-Substituted Indole Carbohydrazide Derivatives: Synthesis and Evaluation of Their Antiplatelet Aggregation Activity,
DARU Journal of Pharmaceutical Sciences,
22: 65 (2014).
[15] Colley H.E., Muthana M., Danson S.J., Jackson L.V., Brett M.L., Harrison J., Coole S.F., Mason D.P., Jennings R.L., Wong M., Tulasi V., Norman D., Lockey P.M., Williams L., Dossetter A.G., Griffen E.J., Thompson M.J.,
An Orally Bioavailable, Indole-3-Glyoxylamide Based Series of Tubulin Polymerization Inhibitors Showing Tumor Growth Inhibition in a Mouse Xenograft Model of Head and Neck Cancer,
J Med. Chem.,
58(23): 9309-33 (2015).
[18] de Miranda A.S., Junior W.B., da Silva V.K., Moreira M.S.A., Castro R.P., Sabino J.R., Liao L.M., Lima L.M., Barreiro E.J.,
Design, Synthesis, Antinociceptive And Anti-Inflammatory Activities of Novel Piroxicam Analogues,
Molecules,
17: 14126-14145 (2012).